Clinical Research: Phase 1 - Phase 4

7 Reasons to Ditch Traditional Monitoring in Favor of a Centralized Strategy

Centralized monitoring’s state-of-the-art approaches and tools are reshaping clinical trials’ efficiency, accuracy, and overall effectiveness. Here we discuss the core methodologies that underpin centralized monitoring—study-level and patient-level data analysis—and how these strategies collaboratively refine the monitoring process. Moreover, we outline seven compelling reasons why shifting from traditional monitoring to a sophisticated, centralized approach is not only beneficial, but essential in today’s fast-evolving clinical research landscape.

Exploring the Two Primary Central Monitoring Approaches

To fully understand the mechanics and advantages of centralized monitoring in clinical trials, it is crucial to examine its two primary approaches: study- and patient-level data analysis. Let us define what we mean by each:

  1. Study-level data analysis in centralized monitoring involves aggregating substantial data volumes from various sites, allowing for the identification of outliers, trends, and systemic issues. It often employs statistical-based analyses, facilitating comparisons across sites, countries, and regions to assess the impact of errors or omissions on trial integrity. It may require large populations and extensive data and is performed less frequently than patient-level data analysis.

  2. Patient-level data analysis in centralized monitoring involves aggregating data from various sources for individual patients, tracking trends over time, and flagging outliers. Typically, it relies on visualization-based analyses and compares each patient to others within or across sites, allowing for the identification of patient-level protocol non-compliance. This type of analysis can be performed promptly, often within a few days of data entry or data availability.

Why Centralized Monitoring Is So Advantageous

To highlight the efficacy of centralized monitoring in clinical trials, let us examine seven key advantages it offers:

  1. Risk assessment and mitigation planning focused on critical data and processes, ensuring alignment with regulatory guidance.
  2. Real-time or near-real-time patient data review.
  3. Increased patient safety and improved data integrity through early issue identification and remediation of issues, achieving an approximately 20 percent faster identification of deviations than traditional monitoring.
  4. Improved data quality and compliance through a combination of central monitoring, onsite monitoring, and site management.
  5. Reduction in the frequency and extent of onsite monitoring visits, thereby decreasing the site burden and aligning with regulatory guidance.
  6. More efficient use of clinical research associates’ (CRA) time and resources, addressing challenges associated with CRA resourcing.
  7. Potential for reducing direct/indirect monitoring costs by up to 20 percent, resulting in enhanced cost efficiency related to monitoring.

Building Your Central Monitoring Toolbox

Premier Research leverages its proprietary study management technology platform, Remarque, which helps clinical trial sponsors and research organizations streamline the management of various Risk-Based Quality Management (RBQM) aspects in clinical trials. This platform covers essential functions such as risk assessments, planning, mitigations, and tracking, as well as supporting the clinical data visualizations and patient profiles that drive centralized monitoring. In addition to the RBQM features, Remarque provides overall management of trial activities, such as start-up, site management, and monitoring using its Clinical Trial Management System (CTMS) capabilities. When used in conjunction, central monitors can share findings directly from the RBQM platform into the CTMS for CRAs to investigate and action – a key advantage for remediating study data issues in a timely manner.

The Path Forward for Centralized Monitoring

For those in clinical development, embracing these centralized monitoring strategies is pivotal. They promise not only to refine current clinical trials but also to spearhead more innovative and efficient research methods. By adopting these approaches, we step into a new era of heightened efficiency, accuracy, and patient safety, driving the field towards ever higher standards of excellence.

If you want to explore how Premier Research and our data-driven approach can empower your clinical trials, we invite you to contact us. Together, we can make centralized monitoring the standard, propelling the clinical research field towards unmatched efficiency and quality.